Related Image: Two Categories of Information Are Key in Seeking SSDI Benefits |
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4(Date:10/13/2008)...nd to Have Higher Sensitivity and Specificity, th...d was the preferred test in all ph...t. 13 /- AT First Diagnostic LLC an,e...stic test kits, today,announced that a recent eval... of Research of the FirstVue(TM) HBSAG Test, was r...
(Date:10/12/2008)...s thin struts designed for more uniform drug ..., and WASHINGTON, Oct. 12 /...y announced comprehensive data from,the TAXUS ATLA...e,multi-center, single-arm, historically controll...Paclitaxel-Eluting Stent System in a variety of,le...
(Date:10/10/2008)...- Inverness Medical,Innovat...ar-patient,diagnostics, monitoring and health mana...the Secretary-General of the United Nations, as pa... the world,s leading,research-based and generic ph...together with senior officials from the United Nat...
(Date:10/9/2008)...sed Sales and Marketing Efforts to Accelerate ..., MENLO PARK, Calif., Oct. 9 /- Eval... for the percutaneous repair of cardiac valves,ha...with the appointment of,Sean Cleary as senior vice...ris Richardson, as vice president of sales., "The...
Breaking Medicine Technology:Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3Banque Centrale Populaire Consolidates Activity Abroad With New Trade Finance Solutions From Misys 24981 1Banque Centrale Populaire Consolidates Activity Abroad With New Trade Finance Solutions From Misys 24981 2AMT to Release Half Year 2008 Results on August 13 2008 6928 1Reminder 3A Webcast Alert 3A Transgenomic Inc Announces Second Quarter 2008 Earnings Release Conference Call Webcast 6927 1Vion Reports 2008 Second Quarter and Six Month Results 24975 1Vion Reports 2008 Second Quarter and Six Month Results 24975 2Vion Reports 2008 Second Quarter and Six Month Results 24975 3Vion Reports 2008 Second Quarter and Six Month Results 24975 4Vion Reports 2008 Second Quarter and Six Month Results 24975 5Vion Reports 2008 Second Quarter and Six Month Results 24975 6... Alequel(TM), an,individualized oral immune regula...r moderate-to-severe Crohn,s disease. Interim,data... Phase II,studies suggest that this investigationa...proved patients, quality of life compared,to place...assah,Medical Center, Jerusalem, Israel, will toda...
...Patient Populations,Studied of Any Drug-Eluting St..., Calif., May 22, 2007,/PRNewswire-FirstCall/ -- X...data from the CUSTOM II clinical trial, which asse...stigational Custom,NX(R) drug-eluting stent (DES) ...ons in patients with coronary artery disease. , Th...
Other Medicine Technology:Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 2Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 3XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 2XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 3XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 4Integrate RFID and bar code technology with the new DR1000 Dual RFID/Bar Code Reader by Precision Dynamics Corporation (PDC). It provides an easy migration from bar codes to RFID tags for healthcare
VerdaSees Navigaton™ software facilitates real time information collection. It is composed of two modules: the first module is a software link between various RFID reader devices and the databa
The AeroScout Engine is a core software component of the AeroScout Visibility System, which enables location-based applications in a wireless LAN environment. Core capabilities of the AeroScout Engin
...a wandering resident from leaving a facility undet... typically have been diagnosed with dementia, Alzh...-risk residents wear a small Watchlet™ brace...e discreetly secured by WatchMate monitors. When a...
Medicine Products: